Bimekizumab in patients with moderate to severe plaque psoriasis by bodyweight: Pooled results from phase 3 trials
Pinter A, Strober B, Rosmarin D, Gisondi P, Vanvoorden V, Peterson L, Madden C, De Cuyper D, Warren R. Bimekizumab in patients with moderate to severe plaque psoriasis by bodyweight: Pooled results from phase 3 trials. SKIN The Journal Of Cutaneous Medicine 2022, 6: s73. DOI: 10.25251/skin.6.supp.73.Peer-Reviewed Original Research